You are currently viewing a new version of our website. To view the old version click .

siRNA Therapeutics: From Bench Lab to Clinics

This special issue belongs to the section “Biopharmaceuticals“.

Special Issue Information

Dear colleagues,

It is our pleasure to invite you to contribute with original research or review manuscripts to a new Special Issue of the Pharmaceuticals journal, entitled “siRNA therapeutics: From Bench Lab to Clinics”.   

The potential of siRNAs as molecular and therapeutic tools was already envisioned soon after their discovery in 1998. Since then, siRNA therapeutics have paved their pathway into clinics. This has been achieved by significant advances in targeted delivery and efficient siRNA stabilization in plasma and serum, concomitantly with the development of novel and powerful experimental tools employed in basic and applied research. Hence, the use of siRNAs in clinics can be considered the result of a close relationship between basic and applied science.

This Special Issue intends to collect both review and original research articles presenting the current state-of-the-art of siRNAs in clinics, either as diagnostic or therapeutic agents. Reports on the development of new carriers for nucleic acid tools and presentation of barriers and challenges that still need to be overcome for their effective use are also welcome.

Dr. Cristina Romero-López
Dr. Alfredo Berzal-Herranz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247